Global /China /Healthcare /Drug Manufacturers - Specialty & Generic /603896

Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

603896

• SSE: 603896 • Delayed

17.48CNY 0.1%

2.58 USD

As of 8 June 2026, Zhejiang Shouxiangu Pharmaceutical Co., Ltd. has a market cap of $511.61M USD, ranking #14976 globally and #4672 in China. It ranks #1332 in the Healthcare sector, and #76 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

14976

Country Rank

4672

Sector Rank

1332

Industry Rank

Key Stats

Market Cap

$511.61MUSD

3.46B CNY

Enterprise Value

$434.7MUSD

2.94B CNY

Revenue (TTM)

$94.57MUSD

640.18M CNY

EBITDA (TTM)

$29.81MUSD

201.92M CNY

Net Income (TTM)

$2.68MUSD

18.17M CNY

EBITDA Margin

32%

Profit Margin

2.8%

PE Ratio

194.1

PS Ratio

5.4

PB Ratio

1.5

EV/EBITDA

13.7

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Zhen-Yu Li open_in_new

Employees

1,118

Founded

1997

Website

sxg1909.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	-3.7%	-7.1%	-15%	-14%	-9.9%	-9.4%	-62%	-39%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	603896 浙江寿仙谷医药股份有限公司 Class A ISIN: CNE100002XJ4 Shares Out.: Shares Outstanding: 198.244M¹ Shares Float: 111.485M² TV: TradingView: SSE: 603896 SA: Stock Analysis: SHA: 603896 YF: Yahoo Finance: 603896.SS GF: Google Finance: SHA: 603896 BA: Barron's: 603896 MS: Morningstar: XSHG: 603896	17.48 CNY	TV: TradingView: SSE: 603896 SA: Stock Analysis: SHA: 603896 YF: Yahoo Finance: 603896.SS GF: Google Finance: SHA: 603896 BA: Barron's: 603896 MS: Morningstar: XSHG: 603896

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

Zhejiang Shouxiangu Pharmaceutical Co., Ltd. engages in the selection, cultivation, processing, and sale of medicinal materials in China. It offers Ganoderma lucidum spore powder and brand broken cell wall powder, as well as broken wall Ganoderma lucidum spore powder granules and powder tablets; Tiepi Fengdou granules; and Tiepi Fengdou Ganoderma lucidum extracts. The company offers its products under the Shouxiangu brand. Zhejiang Shouxiangu Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Jinhua, China.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (China)

Name	Market Cap (USD) diff.	PE	Country
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 3K%	16.0	China
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 2K%	80.6	China
Dong-E-E-Jiao Co., Ltd. SHE: 000423	$5.22B 35.33B CNY 920%	20.0	China
Shijiazhuang Yiling Pharmaceutical Co., Ltd. SHE: 002603	$4.21B 28.47B CNY 722%	20.8	China
Jilin Aodong Pharmaceutical Group Co., Ltd. SHE: 000623	$3.27B 22.12B CNY 539%	8.1	China
China Resources Double-Crane Pharmaceutical Co.,Ltd. SSE: 600062	$2.74B 18.55B CNY 436%	11.5	China

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 7K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 6K%	-	United States
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 2K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 2K%	22.7	India
ABIVAX Société Anonyme EPA: ABVX	$8.79B 7.57B EUR 2K%	-	France
Aurobindo Pharma Ltd. NSE: AUROPHARMA	$8.43B 807.02B INR 2K%	23.1	India

chevron_leftBack